Latest BVF INC/IL Stock Portfolio

$3.14Billion | No. of Holdings #41

BVF INC/IL Performance

2026 Q1+5.19%

YTD+5.19%

2025+18.34%

About BVF INC/IL and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, BVF INC/IL reported an equity portfolio of $3.1 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of BVF INC/IL are KYMR, MLTX, RVMD. The fund has invested 14.6% of it's portfolio in KYMERA THERAPEUTICS INC and 9.5% of portfolio in MOONLAKE IMMUNOTHERAPEUTICS. <br><br> The fund managers got completely rid off ABIVAX SA, REPARE THERAPEUTICS INC (RPTX) and PEPGEN INC (PEPG) stocks. They significantly reduced their stock positions in 4D MOLECULAR THERAPEUTICS IN (FDMT), SEPTERNA INC and MOONLAKE IMMUNOTHERAPEUTICS (MLTX). BVF INC/IL opened new stock positions in ALKERMES PLC (ALKS), SUTRO BIOPHARMA INC (STRO) and ANTERIS TECHNOLOGIES GLOBAL. The fund showed a lot of confidence in some stocks as they added substantially to DISC MEDICINE INC, NEKTAR THERAPEUTICS (NKTR) and IMAGENEBIO INC (IKNA).

BVF INC/IL Equity Portfolio Value

Last Reported on: 15 May, 2026

$3.14Billion

as of May 15, 2026

BVF INC/IL Annual Return Estimates Vs S&P 500

Our best estimate is that BVF INC/IL made a return of 5.19% in the last quarter. In trailing 12 months, it's portfolio return was 56.38%.

Performance
S&P 500

New Buys

Ticker	$ Bought
alkermes plc	70,720,000
sutro biopharma inc	31,182,000
anteris technologies global	16,650,000
onkure therapeutics inc	8,192,940

New stocks bought by BVF INC/IL

Additions

Ticker	% Inc.
disc medicine inc	95.74
nektar therapeutics	64.12
imagenebio inc	38.39
avalo therapeutics inc	20.48
monte rosa therapeutics inc	16.29
stoke therapeutics inc	12.44
foghorn therapeutics inc	10.18
palvella therapeutics inc ne	9.33

Additions to existing portfolio by BVF INC/IL

Reductions

Ticker	% Reduced
4d molecular therapeutics in	-37.8
septerna inc	-21.36
moonlake immunotherapeutics	-18.99
revolution medicines inc	-14.9
immunocore hldgs plc	-13.06
tyra biosciences inc	-7.12
zymeworks inc	-5.19
annexon inc	-4.71

BVF INC/IL reduced stake in above stock

Sold off

Ticker	$ Sold
repare therapeutics inc	-26,867,400
pepgen inc	-12,466,600
abivax sa	-68,510,500
axsome therapeutics inc	-8,357,060

BVF INC/IL got rid off the above stocks

Sector Distribution

BVF INC/IL has about 73.8% of it's holdings in Healthcare sector.

Healthcare
Others

Sector	%
Healthcare	73.8
Others	25.4

Market Cap. Distribution

BVF INC/IL has about 8.9% of it's portfolio invested in the large-cap and mega-cap stocks.

SMALL-CAP
UNALLOCATED
MID-CAP
LARGE-CAP
MICRO-CAP

Category	%
SMALL-CAP	38.2
UNALLOCATED	25.4
MID-CAP	21.5
LARGE-CAP	8.9
MICRO-CAP	6.1

Stocks belong to which Index?

About 59.4% of the stocks held by BVF INC/IL either belong to S&P 500 or RUSSELL 2000 index.

RUSSELL 2000
Others

Index	%
RUSSELL 2000	59.4
Others	40.6

Top 5 Winners (%)		%
IMUX	immunic inc	108.0 %
ELDN	eledon pharmaceuticals inc	104.0 %
	crescent biopharma inc.	54.9 %
NKTR	nektar therapeutics	49.7 %
TYRA	tyra biosciences inc	44.1 %

Top 5 Winners ($)		$
MLTX	moonlake immunotherapeutics	97.6 M
NKTR	nektar therapeutics	61.1 M
RVMD	revolution medicines inc	54.7 M
KYMR	kymera therapeutics inc	30.2 M
TYRA	tyra biosciences inc	24.6 M

Top 5 Losers (%)		%
ADGI	invivyd inc	-47.4 %
OLMA	olema pharmaceuticals inc	-40.4 %
	structure therapeutics inc	-30.6 %
IKNA	imagenebio inc	-24.7 %
KURA	kura oncology inc	-21.5 %

Top 5 Losers ($)		$
	structure therapeutics inc	-74.1 M
OLMA	olema pharmaceuticals inc	-53.4 M
XNCR	xencor inc	-23.2 M
ADGI	invivyd inc	-22.8 M
KURA	kura oncology inc	-19.3 M

BVF INC/IL Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of BVF INC/IL

BVF INC/IL has 41 stocks in it's portfolio. About 62.2% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. MLTX was the most profitable stock for BVF INC/IL last quarter.

$3.14BTotal Value

45.00Positions

15 May, 2026Last Reported

Current holdings of Current Stock Holdings of BVF INC/IL, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
Holdingsorted ascending	% Portfolio	Shares Held	$ Value	% Change
ACIU Ac Immune Sa Ac Immune Sa ACIU BVF INC/IL's holding in Ac Immune Sa over time	1.74%	19,822,400	$54.51M 1.74%	unchanged 0 percentunchanged

ADGI Invivyd Inc Invivyd IncADGI BVF INC/IL's holding in Invivyd Inc over time	0.81%	19,525,000	$25.38M 0.81%	unchanged 0 percentunchanged

ALKS Alkermes Plc Alkermes PlcALKS BVF INC/IL's holding in Alkermes Plc over time	2.25%	2,000,000	$70.72M 2.25%	new position

ANNX Annexon Inc Annexon IncANNX BVF INC/IL's holding in Annexon Inc over time	1.53%	8,698,170	$48.19M 1.53%	decreased 4.71 percentreduced

AVTX Avalo Therapeutics Inc Avalo Therapeutics IncAVTX BVF INC/IL's holding in Avalo Therapeutics Inc over time	0.78%	1,632,840	$24.38M 0.78%	increased 20.48 percentadded

AXSM Axsome Therapeutics Inc Axsome Therapeutics IncAXSM BVF INC/IL's holding in Axsome Therapeutics Inc over time	0%	0.00	$0.00 0%	decreased 100 percentsold off

CGEM Cullinan Therapeutics Inc Cullinan Therapeutics IncCGEM BVF INC/IL's holding in Cullinan Therapeutics Inc over time	2.6%	5,750,680	$81.72M 2.6%	unchanged 0 percentunchanged

CMPX Compass Therapeutics Inc Compass Therapeutics IncCMPX BVF INC/IL's holding in Compass Therapeutics Inc over time	1.31%	7,764,840	$41.08M 1.31%	unchanged 0 percentunchanged

ELDN Eledon Pharmaceuticals Inc Eledon Pharmaceuticals IncELDN BVF INC/IL's holding in Eledon Pharmaceuticals Inc over time	0.62%	6,293,280	$19.38M 0.62%	unchanged 0 percentunchanged

FDMT 4d Molecular Therapeutics In 4d Molecular Therapeutics InFDMT BVF INC/IL's holding in 4d Molecular Therapeutics In over time	0.85%	2,879,290	$26.81M 0.85%	decreased 37.8 percentreduced

FHTX Foghorn Therapeutics Inc Foghorn Therapeutics IncFHTX BVF INC/IL's holding in Foghorn Therapeutics Inc over time	0.89%	5,842,000	$27.92M 0.89%	increased 10.18 percentadded

GHRS Gh Research Plc Gh Research Plc GHRS BVF INC/IL's holding in Gh Research Plc over time	3.87%	8,650,160	$121.62M 3.87%	decreased 2.01 percentreduced

GLUE Monte Rosa Therapeutics Inc Monte Rosa Therapeutics IncGLUE BVF INC/IL's holding in Monte Rosa Therapeutics Inc over time	2.34%	4,460,890	$73.38M 2.34%	increased 16.29 percentadded

IKNA Imagenebio Inc Imagenebio IncIKNA BVF INC/IL's holding in Imagenebio Inc over time	0.18%	1,110,000	$5.55M 0.18%	increased 38.39 percentadded

IMCR Immunocore Hldgs Plc Immunocore Hldgs Plc IMCR BVF INC/IL's holding in Immunocore Hldgs Plc over time	1.24%	1,294,460	$39.03M 1.24%	decreased 13.06 percentreduced

IMUX Immunic Inc Immunic IncIMUX BVF INC/IL's holding in Immunic Inc over time	0.27%	765,297	$8.49M 0.27%	unchanged 0 percentunchanged

IVA Inventiva Sa Inventiva Sa IVA BVF INC/IL's holding in Inventiva Sa over time	0.12%	686,040	$3.81M 0.12%	unchanged 0 percentunchanged

KURA Kura Oncology Inc Kura Oncology IncKURA BVF INC/IL's holding in Kura Oncology Inc over time	2.19%	8,445,770	$68.66M 2.19%	decreased 1.99 percentreduced

KYMR Kymera Therapeutics Inc Kymera Therapeutics IncKYMR BVF INC/IL's holding in Kymera Therapeutics Inc over time	14.6%	5,502,710	$458.32M 14.6%	unchanged 0 percentunchanged

MIRM Mirum Pharmaceuticals Inc Mirum Pharmaceuticals IncMIRM BVF INC/IL's holding in Mirum Pharmaceuticals Inc over time	4.66%	1,584,730	$146.40M 4.66%	increased 5.98 percentadded